Yesterday, 11 December 2025, the Parliament and the Council of
the EU, the two co-legislators in the EU, reached a provisional
agreement on the so called "Pharma Package" during a
trilogue between the European Commission, the Parliament and the
Council of the EU1. The Pharma Package gathers a new
regulation2, as well as new directive3 and is
the biggest reform of EU pharma law since 20 years, amending among
others Directive 2001/83/EC.
The European Commission presented a revision of the
pharmaceutical framework on 26 April 20234. Parliament
adopted its position in April 20245, and the Council of
the EU one year later, under the Polish Presidency of the Council
of the EU6.
This agreement is a success for the Danish Presidency of the
Council of the EU, which listed the adoption of the Pharma Package
as one of the goals of its presidency7.